Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand

Show other versions (1)

<p style="text-align:justify;">Dihydroartemisinin‐piperaquine is an effective drug in the treatment of Plasmodium falciparum and P. vivax malaria. The objective of this study was to evaluate the population pharmacokinetics and pharmacodynamics of piperaquine in patients with P. viva...

Full description

Bibliographic Details
Main Authors:	Tarning, J, Thana, P, Phyo, A, Lwin, K, Hanpithakpong, W, Ashley, E, Day, N, Nosten, F, White, N
Format:	Journal article
Language:	English
Published:	Wiley 2014

Similar Items

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
by: Tarning, J, et al.
Published: (2014)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
by: Tarning, J, et al.
Published: (2008)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
by: Phyo, A, et al.
Published: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2012)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
by: Tarning, J, et al.
Published: (2007)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
by: Tarning, J, et al.
Published: (2012)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
by: Kloprogge, F, et al.
Published: (2015)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
by: Hoglund, R, et al.
Published: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
by: Tarning, J, et al.
Published: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
by: Tarning, J, et al.
Published: (2008)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
by: Adam, I, et al.
Published: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
by: Adam, I, et al.
Published: (2012)

Quantification of the antimalarial piperaquine in plasma.
by: Tarning, J, et al.
Published: (2008)

Characterization of human urinary metabolites of the antimalarial piperaquine.
by: Tarning, J, et al.
Published: (2006)

Semimechanistic pharmacokinetic and pharmacodynamic modeling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria
by: Wattanakul, T, et al.
Published: (2021)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.
by: Rijken, M, et al.
Published: (2011)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria
by: Rijken, M, et al.
Published: (2011)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
by: Permala, J, et al.
Published: (2017)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
by: Lwin, K, et al.
Published: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
by: Lwin, K, et al.
Published: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
by: Rijken, M, et al.
Published: (2011)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
by: White, N
Published: (2013)

Antimalarial effects of rifampin in Plasmodium vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (1994)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
by: Hanboonkunupakarn, B, et al.
Published: (2014)

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
by: Lohy Das, J, et al.
Published: (2017)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
by: Phyo, A, et al.
Published: (2016)

In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
by: Chotivanich, K, et al.
Published: (2004)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
by: Hoglund, R, et al.
Published: (2017)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
by: Annerberg, A, et al.
Published: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
by: Annerberg, A, et al.
Published: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
by: Bergstrand, M, et al.
Published: (2014)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
by: Pukrittayakamee, S, et al.
Published: (1994)

Chloroquine versus hihydroartemisinin-piperaquine with standard high-dose Primaquine given either for 7 days or 14 days in Plasmodium vivax malaria
by: Chu, C, et al.
Published: (2018)

Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.
by: Douglas, N, et al.
Published: (2011)

POPULATION PHARMACOKINETICS OF ANTIMALARIAL DRUGS IN THE TREATMENT OF PREGNANT WOMEN WITH UNCOMPLICATED MALARIA
by: Tarning, J, et al.
Published: (2010)